SON
Basic information
Region (hg38): 21:33543038-33577481
Previous symbols: [ "C21orf50" ]
Links
Phenotypes
GenCC
Source:
- ZTTK syndrome (Strong), mode of inheritance: AD
- ZTTK syndrome (Definitive), mode of inheritance: AD
- ZTTK syndrome (Supportive), mode of inheritance: AD
- ZTTK syndrome (Definitive), mode of inheritance: AD
- ZTTK syndrome (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
ZTTK syndrome | AD | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Gastrointestinal; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Ophthalmologic | 25590979; 27256762; 27545676; 27545680 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (1358 variants)
- ZTTK_syndrome (185 variants)
- SON-related_disorder (106 variants)
- Inborn_genetic_diseases (81 variants)
- not_specified (47 variants)
- Intellectual_disability (9 variants)
- Global_developmental_delay (5 variants)
- See_cases (5 variants)
- Failure_to_thrive (5 variants)
- Hereditary_spastic_paraplegia_17 (1 variants)
- Neurodevelopmental_abnormality (1 variants)
- Developmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SON gene is commonly pathogenic or not. These statistics are base on transcript: NM_000138927.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 381 | 20 | 414 | ||
missense | 605 | 212 | 56 | 882 | ||
nonsense | 30 | 34 | ||||
start loss | 0 | |||||
frameshift | 72 | 33 | 107 | |||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 110 | 43 | 618 | 595 | 76 |
Highest pathogenic variant AF is 0.000016761
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SON | protein_coding | protein_coding | ENST00000356577 | 12 | 34889 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 3.40e-10 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.54 | 1187 | 1.35e+3 | 0.882 | 0.0000763 | 15618 |
Missense in Polyphen | 21 | 34.373 | 0.61095 | 310 | ||
Synonymous | -3.65 | 596 | 493 | 1.21 | 0.0000285 | 5118 |
Loss of Function | 7.74 | 4 | 77.5 | 0.0516 | 0.00000441 | 1074 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00149 | 0.000800 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000512 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00000934 | 0.00000879 |
Middle Eastern | 0.000512 | 0.000381 |
South Asian | 0.0000378 | 0.0000327 |
Other | 0.000195 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein that acts as a mRNA splicing cofactor by promoting efficient splicing of transcripts that possess weak splice sites. Specifically promotes splicing of many cell-cycle and DNA-repair transcripts that possess weak splice sites, such as TUBG1, KATNB1, TUBGCP2, AURKB, PCNT, AKT1, RAD23A, and FANCG. Probably acts by facilitating the interaction between Serine/arginine-rich proteins such as SRSF2 and the RNA polymerase II. Also binds to DNA; binds to the consensus DNA sequence: 5'- GA[GT]AN[CG][AG]CC-3'. May indirectly repress hepatitis B virus (HBV) core promoter activity and transcription of HBV genes and production of HBV virions. Essential for correct RNA splicing of multiple genes critical for brain development, neuronal migration and metabolism, including TUBG1, FLNA, PNKP, WDR62, PSMD3, PCK2, PFKL, IDH2, and ACY1 (PubMed:27545680). {ECO:0000269|PubMed:20581448, ECO:0000269|PubMed:21504830, ECO:0000269|PubMed:27545680}.;
- Disease
- DISEASE: ZTTK syndrome (ZTTKS) [MIM:617140]: An autosomal dominant syndrome characterized by intellectual disability, developmental delay, malformations of the cerebral cortex, epilepsy, vision problems, musculo-skeletal abnormalities, and congenital malformations. {ECO:0000269|PubMed:25590979, ECO:0000269|PubMed:27256762, ECO:0000269|PubMed:27545676, ECO:0000269|PubMed:27545680}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- 0.198
- rvis_EVS
- -1.88
- rvis_percentile_EVS
- 1.99
Haploinsufficiency Scores
- pHI
- 0.882
- hipred
- N
- hipred_score
- 0.485
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.873
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Son
- Phenotype
Zebrafish Information Network
- Gene name
- son
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- shortened
Gene ontology
- Biological process
- microtubule cytoskeleton organization;mitotic cytokinesis;mRNA processing;RNA splicing;negative regulation of apoptotic process;regulation of RNA splicing;regulation of mRNA splicing, via spliceosome;regulation of cell cycle
- Cellular component
- nuclear speck
- Molecular function
- DNA binding;RNA binding;protein binding;RS domain binding